Tribhovandas Bhimji Zaveri Limited (BOM:534369)
India · Delayed Price · Currency is INR 128.35
+2.30 (1.82%)
At close: Apr 2, 2026
BOM:534369 Revenue
Tribhovandas Bhimji Zaveri had revenue of 10.61B INR in the quarter ending December 31, 2025, with 14.40% growth. This brings the company's revenue in the last twelve months to 29.03B, up 11.74% year-over-year. In the fiscal year ending March 31, 2025, Tribhovandas Bhimji Zaveri had annual revenue of 26.20B with 13.99% growth.
Revenue (ttm)
29.03B
Revenue Growth
+11.74%
P/S Ratio
0.30
Revenue / Employee
27.10M
Employees
1,071
Market Cap
8.57B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 26.20B | 3.22B | 13.99% |
| Mar 31, 2024 | 22.99B | -946.82M | -3.96% |
| Mar 31, 2023 | 23.94B | 5.50B | 29.82% |
| Mar 31, 2022 | 18.44B | 5.02B | 37.40% |
| Mar 31, 2021 | 13.42B | -4.68B | -25.86% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Indo Rama Synthetics (India) | 49.07B |
| BCL Industries | 29.32B |
| Oriental Aromatics | 10.02B |
| SEPC Limited | 8.98B |
| Fredun Pharmaceuticals | 5.91B |
| Capital India Finance | 5.91B |
| Andrew Yule & Company | 3.01B |
| Sobhagya Mercantile | 2.06B |
Tribhovandas Bhimji Zaveri News
- 10 months ago - Gold gone in a week: New salesman flees with gold bangles worth 13L from jewellery store - The Times of India